Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-32,423
Closed -$2.45M 2199
2026
Q1
$2.45M Buy
+32,423
New +$2.44M 0.02% 995
2025
Q4
Sell
-13,793
Closed -$931K 1400
2025
Q3
$931K Sell
13,793
-9,292
-40% -$617K 0.01% 1205
2025
Q2
$1.5M Buy
23,085
+5,591
+32% +$335K 0.02% 937
2025
Q1
$1.08M Buy
17,494
+3,790
+28% +$251K 0.02% 966
2024
Q4
$988K Buy
13,704
+10,101
+280% +$789K 0.01% 974
2024
Q3
$294K Buy
3,603
+291
+9% +$23.3K ﹤0.01% 1252
2024
Q2
$246K Buy
3,312
+309
+10% +$23.2K ﹤0.01% 1251
2024
Q1
$234K Buy
+3,003
New +$223K ﹤0.01% 1276
2022
Q1
Sell
-60,914
Closed -$4.66M 265
2021
Q4
$4.66M Buy
60,914
+4,153
+7% +$305K 0.53% 78
2021
Q3
$4.19M Sell
56,761
-5,882
-9% -$441K 0.54% 60
2021
Q2
$4.18M Buy
+62,643
New +$4.19M 0.53% 50

Other funds holding HOLX

Empowered Funds's HOLX Position: Q2 2026 in Review

Empowered Funds sold out of Hologic (HOLX) in Q2 2026, closing a stake of 32,423 shares — an estimated $2.45M sold.

Empowered Funds first reported a position in HOLX in Q2 2021 and held it in 11 quarters. The position peaked at $4.66M in Q4 2021. 3 funds tracked by Wall St. Rank hold HOLX as of Q2 2026.

  • Empowered Funds reported no remaining Hologic position as of Q2 2026 after selling out during the quarter.
  • Empowered Funds sold 32,423 Hologic shares in Q2 2026, an estimated $2.45M.
  • Empowered Funds first reported a position in Hologic in Q2 2021 and held it in 11 quarters.
  • Empowered Funds's Hologic position peaked at $4.66M in Q4 2021.
  • 3 funds tracked by Wall St. Rank held Hologic as of Q2 2026.

Based on Empowered Funds's 13F filing for Q2 2026, filed 17 Aug 2026.